Hims & Hers Health, Inc.

Good afternoon, everyone, and welcome to the HIMSS and HERS third quarter 2022 earnings call. My name is Lisa and I'll be your operator today. At this time, all parties are in a listen-only mode until we conduct a question and answer session, at which time instructions will follow.

Now, I'll turn the call over to Christine Greeney from the Blue Shirt Group to begin. Good afternoon, ladies and gentlemen.

Welcome to the Hims and Hers Health third quarter 2022 earnings call. On the call with me today is Andrew Dudum, co-founder and chief executive officer, as well as Yemi Okupe, chief financial officer. Before I hand you over to Andrew, I need to remind you of legal safe harbor and cautionary declaration. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on our current market, competitors, and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions, or otherwise. please see our most recently filed 10Q and 10K reports for discussion of risk factors as they relate to forward-looking statements. In today's presentation, we have certain non-GAAP financial measures. We refer you to the reconciliation table contained in today's press release available on our Investor Relations website for reconciliation to the most directly comparable GAAP financial measures and related information. You'll find a link to the webcast and investor relations website at investors.forhim.com. After the call, this webcast will be archived on the website for 12 months. And with that, I will now turn the call over to Andrew to begin.